Interplay between aging, lung inflammation/remodeling, and fibronectin EDA in lung cancer progression

References

• American Cancer Society. Cancer facts & figures 2017. Vol. 2017. Atlanta, GA USA: 2017 American Cancer Society.
   Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.
   PubMed Web of Science ®Google Scholar
• Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298–300.
   PubMedGoogle Scholar
• Krishnan KJ, Greaves LC, Reeve AK, Turnbull D. The ageing mitochondrial genome. Nucleic Acids Res. 2007;35:7399–7405.
   PubMed Web of Science ®Google Scholar
• Makinodan T, Marguerite K. Age influence on the immune system. Adv Immunol. 1980;29:287–330.
   PubMedGoogle Scholar
• Campisi J. Cancer and ageing: rival demons? Nat Rev Cancer. 2003;3:339–349.
   PubMed Web of Science ®Google Scholar
• Kirkwood TBL. Understanding the odd science of aging. Cell. 2005;120:437–447.
   PubMed Web of Science ®Google Scholar
• Yao H, Rahman I. Current concepts on the role of inflammation in COPD and lung cancer. Curr Opin Pharmacol. 2009;9:375–383.
   PubMed Web of Science ®Google Scholar
• Park CC, Bissell MJ, Barcellos-Hoff MH. The influence of the microenvironment on the malignant phenotype. Mol Med Today. 2000;6:324–329.
   PubMedGoogle Scholar
• Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in Vivo by integrin blocking antibodies. J Cell Biol. 1997;137:231–245.
   PubMed Web of Science ®Google Scholar
• Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Petersen OW, Turley EA, Bissell MJ. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer. 2002;94:1494–1503.
   PubMedGoogle Scholar
• Sato M, Vaughan MB, Girard L, Peyton M, Lee W, Shames DS, Ramirez RD, Sunaga N, Gazdar AF, Shay JW, et al. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res. 2006;66:2116–2128.
   PubMed Web of Science ®Google Scholar
• Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk for lung cancer. Ann Intern Med. 1987;106:512–518.
   PubMed Web of Science ®Google Scholar
• Yang H, Bocchetta M, Kroczynska B, Elmishad AG, Chen Y, Liu Z, Bubici C, Mossman BT, Pass HI, Testa JR, et al. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci U S A. 2006;103:10397–10402.
   PubMed Web of Science ®Google Scholar
• Philip M, Rowley DA, Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol. 2004;14:433–439.
   PubMed Web of Science ®Google Scholar
• Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. 1993;328:1313–1316.
   PubMed Web of Science ®Google Scholar
• Martins-Green M, Boudreau N, Bissell MJ. Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus. Cancer Res. 1994;54:4334–4341.
   PubMed Web of Science ®Google Scholar
• Aoshiba K, Nagai A. Chronic lung inflammation in aging mice. FEBS Lett. 2007;581:3512–3516.
   PubMed Web of Science ®Google Scholar
• Calabresi C, Arosio B, Galimberti L, Scanziani E, Bergottini R, Annoni G, Vergani C. Natural aging, expression of fibrosis-related genes and collagen deposition in rat lung. Exp Gerontol. 2007;42:1003–1011.
   PubMed Web of Science ®Google Scholar
• Sueblinvong V, Neujahr DC, Mills ST, Roser-page S, Ritzenthaler JD, Guidot D, Rojas M, Roman J. Predisposition for disrepair in the aged lung. Am J Med Sci. 2012;344:41–51.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Ritzenthaler JD, Roman J, Han S. Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression. Am J Respir Cell Mol Biol. 2007;37:681–690.
   PubMed Web of Science ®Google Scholar
• Malik G, Knowles LM, Dhir R, Xu S, Yang S, Ruoslahti E, Pilch J. Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Res. 2010;70:4327–4334.
   PubMed Web of Science ®Google Scholar
• Pontiggia O, Sampayo R, Raffo D, Motter A, Xu R, Bissell MJ, De Kier Joffé EB, Simian M. The tumor microenvironment modulates tamoxifen resistance in breast cancer: A role for soluble stromal factors and fibronectin through β1 integrin. Breast Cancer Res Treat. 2012;133:459–471.
   PubMed Web of Science ®Google Scholar
• George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 1993;119:1079–1091.
   PubMed Web of Science ®Google Scholar
• Muro AF, Chauhan AK, Gajovic S, Iaconcig A, Porro F, Stanta G, Baralle FE. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol. 2003;162:149–160.
   PubMed Web of Science ®Google Scholar
• Muro AF, Moretti FA, Moore BB, Yan M, Atrasz RG, Wilke CA, Flaherty KR, Martinez FJ, Tsui JL, Sheppard D, et al. An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med. 2008;177:638–645.
   PubMed Web of Science ®Google Scholar
• Balducci L, Extermann M. Cancer and aging. An Evolving Panorama. Hematol Oncol Clin North Am. 2000;14:1–16.
   PubMed Web of Science ®Google Scholar
• Hecht SS. Tobacco smoke carcinogen and lung cancer. J Natl Cancer Inst. 1999;91:1194–1210.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Shimizu NK, Asai T, Tsukada H, Oku N. Enhanced experimental tumor metastasis with age in senescence-accelerated mouse. Biol Pharm Bull. 2008;31:847–851.
   PubMed Web of Science ®Google Scholar
• Orr FW, Adamson IYR, Young L. Promotion of pulmonary metastasis in mice by bleomycin-induced endothelial injury. Cancer Res. 1986(46):891–897.
   Google Scholar
• Rybak JN, Roesli C, Kaspar M, Villa A, Neri D. The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res. 2007;67:10948–10957.
   PubMed Web of Science ®Google Scholar
• Femel J, Huijbers EJM, Saupe F, Cedervall J, Zhang L, Roswall P, Larsson E, Olofsson H, Pietras K, Hellman L, et al. Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer. Oncotarget. 2014;5:12418–12427.
   PubMedGoogle Scholar
• Rossnagl S, Altrock E, Sens C, Kraft S, Rau K, Milsom MD, Giese T, Samstag Y, Nakchbandi IA. EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against Cancer. PLoS Biol. 2016;14:1–32.
   Web of Science ®Google Scholar
• Roman J, Ritzenthaler JD, Roser-Page S, Sun X, Han S. Alpha5Beta1-Integrin Expression Is Essential for Tumor Progression in Experimental Lung Cancer. Am J Respir Cell Mol Biol. 2010;43:684–691.
   PubMed Web of Science ®Google Scholar
• Arenberg D, Luckhardt TR, Carskadon S, Zhao L, Amin MA, Koch AE. Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair. Am J Respir Crit Care Med. 2010;182:1030–1037.
   PubMed Web of Science ®Google Scholar
• Wang JP, Hielscher A. Fibronectin: how Its Aberrant Expression in Tumors May Improve Therapeutic Targeting. J Cancer. 2017;8:674–682.
   PubMed Web of Science ®Google Scholar
• Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41:467–470.
   PubMed Web of Science ®Google Scholar